Close

View Older Stories View More Recent Stories

Feb 13, 2019 04:19PM Form SC 13G/A Mirati Therapeutics, Filed by: Broadfin Capital, LLC
Feb 13, 2019 04:18PM Form SC 13G/A LA JOLLA PHARMACEUTICAL Filed by: Broadfin Capital, LLC
Feb 13, 2019 04:14PM Form SC 13G/A Sierra Oncology, Inc. Filed by: Broadfin Capital, LLC
Feb 11, 2019 04:26PM Form SC 13G Egalet Corp Filed by: Broadfin Capital, LLC
Feb 7, 2019 04:24PM Form SC 13G/A Egalet Corp Filed by: Broadfin Capital, LLC
Jan 29, 2019 04:23PM Form SC 13G Aclaris Therapeutics, Filed by: Broadfin Capital, LLC
Jan 23, 2019 08:38AM PlacementTracker Publishes 2018 PIPE and Private Placement Markets League Tables
Jan 22, 2019 09:03AM Form SC 13G/A ARATANA THERAPEUTICS, Filed by: Broadfin Capital, LLC
Jan 22, 2019 08:59AM Form 3 ARATANA THERAPEUTICS, For: Jan 18 Filed by: Broadfin Capital, LLC
Jan 3, 2019 04:49PM Form SC 13G Neos Therapeutics, Inc. Filed by: Broadfin Capital, LLC
Jan 3, 2019 08:43AM Avadel Pharma (AVDL) Reports Resignation of CEO Michael S. Anderson, Appoints COO Gregory Divis as Interim CEO; Names Geoffrey Glass as Board Chair & Eric Ende to Board
Jan 3, 2019 08:30AM Avadel Pharmaceuticals Announces Changes to Management Team and Board of Directors
Dec 27, 2018 05:35PM Form 4 NOVELION THERAPEUTICS For: Dec 24 Filed by: Broadfin Capital, LLC
Dec 27, 2018 05:21PM Form SC 13G/A NOVELION THERAPEUTICS Filed by: Broadfin Capital, LLC
Dec 13, 2018 04:04PM Form 3 AVADEL PHARMACEUTICALS For: Dec 07 Filed by: Broadfin Capital, LLC
Dec 11, 2018 05:01PM Form SC 13D AVADEL PHARMACEUTICALS Filed by: Broadfin Capital, LLC
Dec 11, 2018 08:31AM Avadel Pharma (AVDL) Announces Kevin Kotler to Board
Dec 11, 2018 08:30AM Avadel Pharmaceuticals Appoints Kevin Kotler to the Company’s Board of Directors
Nov 28, 2018 04:36PM Form SC 13G/A Corium International, Filed by: Broadfin Capital, LLC
Nov 28, 2018 04:16PM Form 4 Corium International, For: Nov 27 Filed by: Broadfin Capital, LLC
Nov 14, 2018 08:12AM Form 13F-HR Broadfin Capital, LLC For: Sep 30
Oct 23, 2018 08:38AM PlacementTracker Publishes Q3 2018 Private Placement Market League Tables
Oct 15, 2018 04:16PM Form SC 13G/A Corium International, Filed by: Broadfin Capital, LLC
Sep 7, 2018 04:09PM Form SC 13G Sierra Oncology, Inc. Filed by: Broadfin Capital, LLC
Aug 22, 2018 08:00AM Exicure, Inc. Announces Expected Closing of Approximately $22 Million Private Placement Offering
Aug 14, 2018 08:20AM Form 13F-HR Broadfin Capital, LLC For: Jun 30
Aug 13, 2018 06:00PM Form 4 NOVELION THERAPEUTICS For: Aug 09 Filed by: Broadfin Capital, LLC
Aug 8, 2018 05:12PM Form SC 13D/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
Jul 19, 2018 08:38AM PlacementTracker Publishes First Half 2018 PIPE Market League Tables
Jun 11, 2018 04:11PM Form SC 13G ADMA BIOLOGICS, INC. Filed by: Broadfin Capital, LLC
May 29, 2018 04:47PM STRATA Skin Sciences Announces Closing of a $17 Million Equity Financing and the Formal Appointment of New Management to Accelerate Growth and Enrich its XTRAC® Business Strategy
May 24, 2018 05:10PM Form SC 13G/A Recro Pharma, Inc. Filed by: Broadfin Capital, LLC
May 24, 2018 05:04PM Form 4 Recro Pharma, Inc. For: May 24 Filed by: Broadfin Capital, LLC
May 23, 2018 07:33PM Form 3 BIODELIVERY SCIENCES For: May 21 Filed by: Broadfin Capital, LLC
May 22, 2018 08:30AM BioDelivery Sciences (BDSI) Names Peter Greenleaf as Chairman; Closes $50 Million Equity Financing
May 22, 2018 08:29AM BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
May 22, 2018 08:29AM BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
May 21, 2018 05:34PM Form SC 13D/A BIODELIVERY SCIENCES Filed by: Broadfin Capital, LLC
May 17, 2018 09:22AM Pre-Open Movers 05/17: (WWE) (LOXO) (NTES) Higher; (JNCE) (JCP) (ACXM) Lower (more...)
May 17, 2018 08:09AM BioDelivery Sciences (BDSI) Reports Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
May 17, 2018 08:01AM BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
May 17, 2018 08:01AM BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
May 14, 2018 04:58PM Form 13F-HR Broadfin Capital, LLC For: Mar 31
May 10, 2018 08:30AM Novelion Therapeutics Reports First Quarter 2018 Financial Results
May 10, 2018 08:30AM Novelion Therapeutics Reports First Quarter 2018 Financial Results
May 3, 2018 09:01AM BioDelivery Sciences Confirms Receipt of Notice of Intent to Nominate Directors by Broadfin Capital
View More Recent Stories View Older Stories